Lipoprotein modification and atherosclerosis in aging

Experimental Gerontology

Volumn 34, Issue 4, 1999, Pages 527-537

  Reaven, Peter D ^a   Napoli, Claudio ^b   Merat, Shiva ^c   Witztumc, Joseph L ^c  

^a CARL T HAYDEN VA MEDICAL CENTER   (United States)

^b Special Section of Surgical Digestive Endoscopy   (Italy)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; AUTOANTIBODY; CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; LYSINE;

AGING; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MENOPAUSE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0033180078     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(99)00037-6     Document Type: Article

References (59)

1. Abe H., Yamada N., Kamata K., Kuwaki T., Shimada M., Osuga J., Shionoiri F., Yahagi N., Kadowaki T., Tamemoto H., Ishibashi S., Yazaki Y., Makuuchi M. Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J Clin Invest. 101:1998;1784-1788.
2. Abete P., Napoli C., Santoro G., Ferrara N., Tritto I., Chiariello M., Rengo F., Ambrosio G. Age-related decrease in cardiac tolerance to oxidative stress. J Mol Cell Cardiol. 31:1999;227-236.
3. Aho K., Seuri M., Keikola J., Alfthan G., Vaarala O., Palosuo T. Serum antibodies to oxidised low-density lipoprotein. Lancet. 344:1994;197-200.
4. Arnal J.F., Clamens S., Pechet C., Negre-Salvayre A., Allera C., Girolami J.-P., Salvayre R., Bayard F. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA. 93:1996;4108-4113.
5. Azhar S., Cao L., Reaven E. Alteration of the adrenal antioxidant defense system during aging in rats. J Clin Invest. 96:1995;1414-1424.
6. Baynes J.W., Thorpe S.R. Role of oxidative stress in diabetic complications A new perspective on an old paradigm . Diabetes. 48:1999;1-9.
7. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol Rev. 78:1998;547-571.
8. Benfante R., Reed D., Frank J. Do coronary heart disease risk factors measured in the elderly have the same predictive roles as in the middle aged. Comparisons of relative and attributable risks. Ann Epidemiol. 2:1992;273-282.
9. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A., Watson A.B., Lusis A.J. Atherosclerosis: basic mechanisms. Oxidation inflammation, and genetics. Circulation. 91:1995;2488-2496.
10. Cand F., Verdetti J. Superoxide dismutase, glutathione peroxidase, catalase, and lipid peroxidation in the major organs of the aging rats. Free Rad Biol Med. 7:1989;59-63.
11. Craig W.Y., Ledue T.B. Changes in serum antibodies to oxidised low-density lipoprotein with age. Lancet. 344:(8919):1994;411.
12. Cutler R.G. Urate and ascorbate their possible role as antioxidants in determining longevity of mammalian species . Arch Gerontol Geriatr. 3:1985;321-348.
13. Cutler R.G. Antioxidants and aging. Am J Clin Nutr. 53:1991;373S-379S.
14. Denke M.A., Grundy S.M. Hypercholesterolemia in elderly persons resolving the treatment dilemma . Ann Intern Med. 112:1990;780-792.
15. Fruebis J., Bird D.A., Pattison J., Palinski W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J Lipid Res. 38:1997;2455-2464.
16. Gallotta G., Iazzetta N., Milan G., Ruocco A., Napoli C., Postiglione A. Prevalence of peripheral arterial disease in an elderly rural population of Southern Italy. Gerontology. 43:1997;289-295.
17. Green M.S., Heiss G., Rifkind B.M., Cooper G.R., Williams O.D., Tyroler H.A. The ratio of plasma high-density lipoprotein cholesterol to total and low-density lipoprotein cholesterol: age-related changes and race and sex differences in selected North American populations. The Lipid Research Clinics Program Prevalence study. Circulation. 72:1985;93-104.
18. Harris M.I., Hadden W.C., Knowler W.C. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 years. Diabetes. 36:1987;523-534.
19. Hess M.L., Manson N.H. Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. Mol Cell Cardiol. 16:1984;969-985.
20. Holm P., Korsgaard N., Shalmi M., Andersen H.L., Hougaard P., Skouby S.O., Stender S. Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. J Clin Invest. 100:1997;821-828.
21. Jira W., Spiteller G., Schramm A. Increase in hydroxy fatty acids in human low density lipoproteins with age. Chem Phys Lipids. 84:1996;165-173.
22. Khalil, A., Wagner, J. R., Lacombe, G., Dangoisse, V., Dangoisse, V., & Fulop, Jr., T. (1996). Increased susceptibility of LDL to oxidation by gamma-radiolysis with age. FEBS Lett, 392, 45-48.
23. Kinlay S., Selwyn A.P., Delangrange D., Creager M.A., Libby P., Ganz P. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points. Curr Opin Lipidol. 7:1996;389-397.
24. Knigh J.A., Smith S.E., Kinder V.E., Anstall H.B. Reference intervals for plasma lipoperoxides age, sex, and specimen-related variations . Clin Chem. 33:1987;2289-2291.
25. Knopp R.H., Warnick G.R., Walden C.E., Wahl P.W., Hoover J.J., Bergelin R.O., Ogilvie J.T., Albers J.J., Hazard W.R. Relationship of gender, sex hormone use and age with lipoprotein cholesterol. Atheroscl. 39:1981;133-135.
26. Lecerf J., Rossignol A., Varicel E., Thies F., Farnier M., Logarde M. Variations in the fatty acid composition of lipid classes from lipoproteins in elderly women. Atheroscl. 98:1993;241-249.
27. Lee C., Sigari F., Segrado T., Hörkkö S., Hama S., Subbaiah P.V., Miwa M., Navab M., Witztum J.L., Reaven P.D. All Apolipoprotein B containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified modulation of lipoprotein bioactivity by platelet activating factor acetylhydrolase . Art Thromb Vasc Biol. 19:1999;1437-1446.
28. Lykkesfeldt J., Hagen T.M., Vinarsky V., Ames B.N. Age-associated decline in ascorbic acid concentration, recycling, and biosynthesis in rat hepatocytes - reversal with (R)-alpha-lipoic acid supplementation. FASEB J. 12:1998;1183-1189.
29. Maggi, E., Perani, G., Finardi, G., Franceschi, C., & Bellomo, G. (1993). LDL oxidation in aging. In: Corongiu, F., Banni. S., Dessi, A., Rice-Evans, C. (Eds.), Free Radicals and Antioxidants in Nutrition (pp. 427-437).
30. McCord J.M. Free radicals and inflammation protection of synovial fluid by superoxide dismutase . Science. 185:1974;529-531.
31. McGarry P., Solberg L.A., Guzman M.A., Strong J.P. Cerebral atherosclerosis in New Orleans. Comparisons of lesions by age, sex, and race. Lab Invest. 52:1985;533-539.
32. McGill, H. C. (1997). Childhood nutrition and adult cardiovascular disease. Nutr Rev, 55, S2-8, S8-11.
33. Mihara M., Uchiyama M., Fukuzawa K. Thiobarbituric acid value on fresh homogenate of rat as a parameter of lipid peroxidation in aging, CC14 intoxication, and vitamin E deficiency. Biochem Med. 23:1980;302-311.
34. Nagaraj R.H., Portero-Otin M., Monnier V.M. Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes. Arch Biochem Biophys. 325:1966;152-158.
35. Napoli C., Abete P., Corso G., Malorni A., Postiglione A., Ambrosio G., Cacciatore F., Rengo F., Palumba G. Increased low-density lipoprotein peroxidation in elderly men. Cor Art Dis. 8:1997;129-136.
36. Napoli C., Ambrosio G., Scarpato N., Corso G., Palumba G., D'Armiento F.P., Mancini F.P., Malorni A., Formisano S., Ruocco A., Caĺi A., Chiariello M. Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia. American Heart Journal. 133(5:1997;585-595.
37. Napoli C., Mancini F.P., Corso G., Malorni A., Crescenzi E., Postiglione A., Palumbo G. A simple and rapid purification procedure minimizes spontaneous oxidative modifications of low density lipoprotein and lipoprotein (a). J Biochem. 121:1997;1096-1101.
38. Napoli C., D'Armiento F.P., Mancini F.P., Postiglione A., Witztum J.L., Palumbo G., Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 100:1997;2680-2690.
39. Palinski W., Koschinsky T., Butler S.W., Miller E., Vlassara H., Cerami A., Witztum J.L. Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits. Art Thromb Vasc Biol. 15:1995;571-582.
40. Palinski W., Tangirala R.K., Miller E., Young S.G., Witztum J.L. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Art Thromb Vasc Biol. 15:1995;1569-1576.
41. Pamplona R., Portero-Otin M., Riba D., Ruiz C., Prat J., Bellmunt M.J., Barja G. Mitochondrial membrane peroxidizability index is inversely related to maximum life span in mammals. J Lipid Res. 39:1998;1989-1994.
42. Reaven P.D., Witztum J.L. Oxidized low density lipoproteins in atherogenesis role of dietary modification . Ann Rev Nutr. 16:1996;51-71.
43. Reaven P., Merat S., Casanada F., Sutphin M., Palinski W. Effect of streptozotocin-induced hyperglycemia on lipid profiles, formation of advanced glycation Endproducts in lesions, and extent of atherosclerosis in LDL receptor-deficient mice. Art Thromb Vasc Biol. 17:1997;2250-2256.
44. Rifici V.A., Khachadurian A.K. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol. Metabolism. 41:1992;1110-1114.
45. Sack M.N., Rader D.J., Cannon R.O. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 343:1994;269-270.
46. Sawada M., Carlson J.C. Biochemical changes associated with the mechanism controlling superoxide radical formation in the aging rotifer. J Cell Biochem. 44:1990;153-165.
47. Schmuck A., Fuller C.J., Devaraj S., Jialal I. Effect of aging on susceptibility of low density lipoproteins to oxidation. Clin Chem. 41:1995;1628-1632.
48. Simons L., Reichl D., Myant N.B., Mancini M. The metabolism of apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinemia in the homozygous form. Atherosclerosis. 21:1975;283-289.
49. Sohal R.S., Wolfe L.S. Lipofuscin characteristics and significance . Progr Brain Res. 70:1986;171-183.
50. Steinbrecher U.P., Witztum J.L. Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes. 33:1984;130-134.
51. Stulnig T.M., Jurgens G., Chen Q., Moll D., Schonitzer D., Jarosch E., Wick G. Properties of low density lipoproteins relevant to oxidative modifications change paradoxically during aging. Atheroscl. 126:1996;85-94.
52. Tanaka K., Masuda J., Imamura T., Sueishi K., Nakashima T., Sakurai I., Shozawa T., Hosoda Y., Nishiyama Y. A nationwide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis. 72:1988;143-156.
53. Tomalsoff J.M., Ono T., Cutler R.G. Superoxide dismutase correlation with lifespan and specific metabolic rate in primate species . Proc Natl Acad Sci USA. 77:1980;2777-2781.
54. The Expert Panel. (1993). Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA, 269, 3015-3023.
55. Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med. 28:1996;419-426.
56. Walzem R.L., Watkins S., Frankel E.N., Hansen R.J., German J.B. Older plasma lipoproteins are more susceptible to oxidation a linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease . Proc Natl Acad Sci USA. 92:1995;7460-7464.
57. Williams S.B., Cusco J.A., Roddy M.A., Johnston M.T., Creager M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 27:1996;567-574.
58. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
59. Ylä-Herttuala S. Is oxidized low-density lipoprotein present in vivo? Curr Opinion Lipid. 9:1998;337-344.